WILLIAM ROUSE: Open Payments
NPI 1477165322 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 12 payments from 6 companies in 2025. Trend: 2023 $456 · 2024 $303 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| ABBVIE INC. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
Products named: UZEDY, INGREZZA, VRAYLAR, LYBALVI, ABILIFY MAINTENA, INVEGA SUSTENNA, SPRAVATO, ARISTADA.
Industry payments across AL — which companies pay providers there.
